AI Analysis AI Analysis of NONOF AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add NONOF to Watchlist?
Some Reasons Why To Add NONOF:
  • High gross margin of 81.8%
  • Beat earnings estimates in 3 of the last 4 quarters
  • Strong operating margin of 45.3%
PDF

Novo Nordisk A/S stock price took a fall of -7.62% on Friday
(Updated on Jul 31, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 31, 2026

The Novo Nordisk A/S stock price fell by -7.62% on the last day (Friday, 31st Jul 2026) from $49.80 to $46.01. During the last trading day the stock fluctuated 7.52% from a day low at $44.94 to a day high of $48.32. The price has fallen in 6 of the last 10 days and is down by -9.34% for this period. Volume has increased on the last day by 194 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 200 shares were bought and sold for approximately $9.20 thousand.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $45.21 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 14.41% during the next 3 months and, with a 90% probability hold a price between $51.72 and $59.28 at the end of this 3-month period.

NONOF Signals & Forecast

There are few to no technical positive signals at the moment. The Novo Nordisk A/S stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $49.26 and $47.92. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, July 17, 2026, and so far it has fallen -9.34%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Novo Nordisk A/S gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Novo Nordisk A/S stock

Novo Nordisk A/S finds support from accumulated volume at $44.52 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $3.38 between high and low, or 7.52%. For the last week the stock has had daily average volatility of 6.04%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NONOF) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Novo Nordisk A/S to open at $46.42, and during the day (based on 14 day Average True Range), to move between $44.66 and $47.35, which gives a possible trading interval of +/-$2.69 (+/-6.01%) up or down from last closing price. If Novo Nordisk A/S takes out the full calculated possible swing range there will be an estimated 6.01% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $46.84 (1.81%) than the support at $44.52 (3.23%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Novo Nordisk A/S will release earnings BMO on Wednesday, August 05, 2026.The consensus among the analysts for the expected earnings (EPS) is $0.766. We will update the financials statements for Novo Nordisk A/S, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 6.16% in the first trading day after earnings release.

Is Novo Nordisk A/S stock A Buy?

The Novo Nordisk A/S stock holds several negative signals and despite the positive trend, we believe Novo Nordisk A/S will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -4.818 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $46.42 ( 0.91%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

NONOF Performance

Trading levels for NONOF

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 49.80 8.25%
R2 48.51 5.45%
R1 47.71 3.71%
Price 46.01
S1 45.13 -1.90%
S2 44.33 -3.63%
S3 43.04 -6.44%

Accumulated Volume Support & Resistance Levels

Level Price
R3 49.58 7.77%
R2 47.97 4.27%
R1 46.84 1.81%
Price 46.01
S1 44.52 -3.23%
S2 44.29 -3.73%
S3 44.19 -3.94%

NONOF Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Feb 04, 2026 Mar 30, 2026 Mar 31, 2026 $1.25 2.57%
2 Mar 27, 2026 Mar 27, 2026 Mar 31, 2026 $1.25 2.81%
3 Aug 06, 2025 Aug 18, 2025 Aug 19, 2025 $0.586 1.07%
4 Aug 15, 2025 Aug 15, 2025 Aug 19, 2025 $0.585 1.15%
5 Feb 05, 2024 Mar 31, 2025 Apr 01, 2025 $1.14 1.69%

FAQ

What is the symbol for Novo Nordisk A/S Stock and on which exchange is it traded?
The symbol for Novo Nordisk A/S is NONOF and it is traded on the PINK (Pink Sheets).

Should I buy or sell Novo Nordisk A/S Stock?
The Novo Nordisk A/S stock holds several negative signals and despite the positive trend, we believe Novo Nordisk A/S will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Novo Nordisk A/S Stock?
Novo Nordisk A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Novo Nordisk A/S Stock.

What's the current price of Novo Nordisk A/S Stock?
As of the end of day on the Jul 31, 2026, the price of an Novo Nordisk A/S (NONOF) share was $46.01.

What is the 52-week high and low for Novo Nordisk A/S Stock?
The 52-week high for Novo Nordisk A/S Stock is $64.75 and the 52-week low is $34.00.

What is the market capitalization of Novo Nordisk A/S Stock?
As of the Jul 31, 2026, the market capitalization of Novo Nordisk A/S is 204.376B.

When is the next earnings date for Novo Nordisk A/S?
The upcoming earnings date for Novo Nordisk A/S is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT NOVO NORDISK A/S
Novo Nordisk A/S
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the ...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE